ANRO
Alto Neuroscience, Inc.
26.50$
-2.5%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| -4,410.5% | – | – | – | – | |
| 69.0% | – | – | – | – | |
| 108.1% | – | – | – | – | |
| -272.4% | – | – | – | – | |
| 323.8% | – | – | – | – | |
| -323.8% | – | – | – | – | |
| 0.0% | – | – | – | – | |
| 15,089.5% | – | – | – | – | |
| 10,331.4% | – | – | – | – | |
| -4,734.3% | – | – | – | – |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.